Your healthcare provider may customize your titration schedule depending on your individual needs, tolerability, and treatment goals
Exendin-4, GLP-1 (7-36), and GLP-1 (9-36) increased DNA synthesis in hCAECs with subsequent cell proliferation;(Erdogdu et al., 2010) while exendin-4 and GLP-1 (7-36) protected hCAECs against lipoapoptosis (Erdogdu et al., 2013)
A few are piloting outcomes-based models , where ongoing access to medication depends on participation in coaching or lifestyle change programs
Nuseas, vmitos, opresin y dolor en el pecho, debilidad general
Some may focus on weight loss, while others want better blood sugar control for type 2 diabetes